brain
tissu
patient
clinic
definit
multipl
sclerosi
ms
control
brain
tissu
patient
without
neurolog
diseas
test
presenc
human
coronavir
rna
four
pcr
assay
primer
specif
nprotein
human
coronaviru
strain
three
pcr
assay
primer
specif
nucleocapsid
protein
human
coronaviru
strain
perform
sporad
posit
pcr
assay
observ
patient
control
pcr
assay
howev
result
reproduc
differ
proport
posit
signal
ms
patient
compar
control
evid
chronic
infect
human
coronavirus
strain
brain
tissu
patient
ms
control
found
studi
caus
multipl
sclerosi
ms
far
unknown
hered
environment
factor
consid
import
environment
factor
especi
virus
subject
extens
research
discuss
specif
agent
far
definit
link
ms
human
coronavirus
worldwid
caus
common
cold
usual
associ
seriou
diseas
human
mous
hepat
viru
murin
coronaviru
caus
mslike
demyelin
diseas
central
nervou
system
rodent
anim
model
use
model
ms
evid
presenc
coronavir
gene
human
brain
tissu
found
use
polymeras
chain
reaction
pcr
situ
hybrid
aim
studi
examin
brain
tissu
danish
ms
patient
human
coronavir
rna
sequenc
use
revers
transcriptas
rt
pcr
brain
tissu
obtain
patient
clinic
definit
ms
two
danish
tissu
collect
patient
chronic
progress
ms
mani
year
data
age
death
avail
patient
median
year
rang
year
patient
clinic
definit
ms
specimen
area
macroscop
visibl
plaqu
sampl
periventricular
mostli
white
matter
brain
specimen
store
rna
extract
older
tissu
collect
year
death
rang
wherea
newer
brain
collect
control
brain
tissu
obtain
consecut
routin
autopsi
autopsi
brain
routin
perform
patient
shown
clinic
sign
possibl
intracerebr
patholog
prior
death
patholog
report
review
patient
histori
neurolog
diseas
cerebr
lesion
previou
cerebr
infarct
patient
moder
cerebr
arteriosclerosi
patient
control
normal
cerebr
patholog
caus
death
cancer
lower
respiratori
tract
infect
acut
myocardi
infarct
pancreat
control
autopsi
report
avail
patient
posit
control
cell
cultur
supernat
fluid
contain
human
coronaviru
strain
atcc
strain
atcc
use
cultur
cell
atcc
cell
supernat
contain
tcid
tissu
cultur
infect
dose
ml
use
posit
control
cultur
cell
atcc
cell
supernat
contain
tcid
ml
use
posit
control
extract
rna
brain
tissu
perform
homogen
guanidinium
thiocyan
buffer
follow
ultracentrifug
cesium
chlorid
cscl
step
gradient
extract
rna
evalu
absorpt
spectrophotometri
nm
rtpcr
specif
myelin
basic
protein
mbp
mrna
sampl
neg
mbp
absorpt
ratio
lower
exclud
analysi
eight
primer
pair
use
present
studi
tabl
combin
eight
differ
rtpcr
assay
tabl
sensit
pcr
assay
test
serial
dilut
viral
supernat
contain
pcr
reaction
carri
reaction
volum
concentr
primer
dnapolymeras
amplitag
perkin
elmer
cetu
mgcl
optim
assay
extens
tabl
detail
primer
combin
concentr
reagent
avail
correspond
author
request
prepcr
procedur
filter
tip
dedic
pipett
set
use
pcr
product
visual
uv
transillumin
follow
electrophoresi
agaros
subsequ
southern
blot
nytran
filter
blot
perform
describ
except
setup
invert
overnight
transfer
nytran
filter
paper
rins
briefli
ssc
nucleic
acid
immobil
bake
vacuum
h
subsequ
blot
prehybrid
h
follow
hybrid
overnight
dna
probe
stringent
wash
perform
ssc
buffer
salin
sodium
citrat
probe
produc
pcr
describ
refer
strain
label
nick
translat
bionick
life
technolog
rockvil
usa
probe
detect
perform
use
photogen
bionick
detect
kit
accord
manufactur
instruct
result
regist
posit
band
expect
size
present
hybrid
cycl
sequenc
perform
accord
manufactur
instruct
perk
elmer
appli
biosystem
california
usa
p
datp
radioact
label
reaction
perform
accord
manufactur
instruct
electrophoresi
run
polyacrylamid
gel
gel
dri
filter
paper
xray
film
use
visual
radioact
band
dri
gel
total
specimen
individu
assay
rtpcr
assay
specif
mbp
mrna
twentyon
specimen
ratio
lower
also
neg
mbp
specimen
exclud
result
remain
specimen
describ
specimen
yield
mean
rnag
brain
tissu
slightli
lower
report
literatur
use
method
extract
one
ms
patient
complet
exclud
rna
detect
sampl
extract
sensit
assay
rang
nest
pcr
assay
tissu
cultur
infect
dose
specimen
test
posit
least
one
assay
exampl
pcr
result
shown
fig
comparison
ms
group
control
individu
count
use
first
specimen
extract
assay
perform
tabl
one
nest
pcr
assay
patient
found
posit
result
could
reproduc
repeat
pcr
pcr
analys
neither
differ
specimen
pcr
product
sequenc
found
ident
expect
sequenc
human
coronavir
nucleocapsid
gene
proport
differ
sporad
posit
signal
ms
group
control
patient
control
consist
posit
neither
reanalysi
rna
extract
differ
specimen
individu
yield
rna
extract
satisfactori
specimen
contain
amplifi
rna
determin
mbp
mrna
rtpcr
assay
specimen
neg
mbp
exclud
may
either
degrad
rna
contain
substanc
inhibitori
rtpcr
specimen
gave
posit
rtpcr
mbp
low
total
absorpt
low
ratio
thu
exclud
due
low
total
rna
content
remain
specimen
optim
yield
qualiti
amount
total
rna
brain
tissu
decreas
significantli
least
h
postmortem
howev
specif
mrna
may
shorter
halflif
premortem
postmortem
factor
may
increas
decreas
express
specif
mrna
mainli
import
attempt
quantit
rtpcr
studi
mbprna
amplifi
specimen
includ
older
tissu
date
back
describ
storag
rna
year
may
affect
use
rna
vitro
express
studi
suffici
partial
fulllength
rna
may
remain
pcr
studi
rtpcr
assay
yield
scatter
posit
signal
simpl
technic
explan
found
inconsist
posit
signal
one
explan
could
low
level
presenc
coronavir
target
gene
specimen
order
less
copi
target
gene
present
initi
amplif
pcr
process
becom
problemat
due
probabl
target
gene
copi
present
aliquot
probabl
primer
anneal
specif
templat
low
level
presenc
coronavirus
human
brain
could
possibl
ordinari
episod
common
cold
due
coronavirus
anim
model
murin
coronavirus
found
enter
brain
mice
rat
owl
monkey
intranas
inocul
hematogen
spread
direct
entri
via
olfactori
nerv
found
fals
posit
result
due
contamin
rule
extens
precaut
taken
avoid
contamin
ung
carri
prevent
use
assay
neg
control
interspers
patient
sampl
consist
neg
compar
result
present
studi
literatur
tabl
found
higher
frequenc
posit
control
group
previous
report
could
bia
previou
studi
due
specimensassay
record
group
patient
ms
two
studi
describ
hcv
genom
human
brain
tissu
count
patient
least
one
posit
signal
disregard
neg
result
repeat
specimen
murray
et
al
use
situ
hybrid
techniqu
found
patient
ms
posit
section
examin
posit
control
group
section
posit
posit
section
cell
posit
studi
compar
present
studi
regard
pauciti
posit
signal
observ
talbot
et
al
examin
specimen
patient
ms
specimen
control
sampl
posit
patient
found
posit
howev
result
posit
specimen
reproduc
contrast
present
studi
weight
pool
data
tabl
show
patient
ms
posit
compar
control
estim
could
bias
neg
studi
less
like
publish
present
result
provid
evid
chronic
infect
human
coronavirus
strain
brain
tissu
patient
ms
control
howev
posit
signal
found
could
sporad
contamin
low
level
viral
express
brain
tissu
rule
tabl
combin
tabl
use
weight
mean
confid
interv
pool
differ
p
